Dana-Farber Boston Children’s Cancer and Blood Disorders Center combines expertise of Dana-Farber Cancer Institute and Boston Children’s Hospital to offer seamless, integrated care for children with all types of cancer and blood disorders, including the rarest and most complex cases. The center has more than 150 oncology and hematology experts, performing more than 125 stem cell transplants each year. The program was the first in New England to offer MIBG therapy to treat high-risk neuroblastoma, including relapsed or refractory neuroblastoma, and is currently one of only about 10 hospitals in the country to provide this therapy. With more than 200 open clinical trials, patients have access to leading-edge precision medicine research that provides valuable information about their unique tumor profile. Additionally, the program offers the most advanced treatments including CAR T-cell therapy, gene therapy and immunotherapy for children with cancer or blood disorders.
